Hawaii Cancer Survivor Pushes Congress for Research Funds

When Michelle Lavarre traveled from Kauai to the nation's capital this week, she carried more than just her own cancer survival story. She brought hope for thousands of Hawaii families who will hear the words "you have cancer" in 2026.

Lavarre joined forces with U.S. Senator Brian Schatz, Representative Ed Case, and about 800 cancer patients and survivors at the American Cancer Society Cancer Action Network's annual Leadership Summit and Lobby Day. Their ask was clear: increase funding for cancer research and pass the Clinical Trial Modernization Act.

The proposed act would remove financial barriers that keep people from accessing clinical trials, especially those in rural communities like Kauai. Right now, the cost of participating in potentially life-saving research stops many patients before they can even try.

The numbers tell a powerful story of what federal funding has already accomplished. Over the past 30 years, steady investment in cancer research has led to a 34% drop in cancer mortality rates across America.

That progress happens at key agencies like the National Institutes of Health, the National Cancer Institute, and the Centers for Disease Control and Prevention. Each dollar invested translates to discoveries that save real lives in real communities.

The Ripple Effect

The impact of this advocacy work extends far beyond Hawaii's shores, but the islands feel it deeply. Nearly 9,500 Hawaii residents will receive a cancer diagnosis this year, each one a neighbor, a parent, a friend.

When research funding increases, rural communities benefit most. Hawaii's geographic isolation makes accessing cutting-edge treatments challenging, so bringing clinical trials closer to patients changes everything.

Lavarre shared both her personal cancer journey and her professional experience working with patients during the meetings. Her dual perspective gave lawmakers a complete picture of why this funding matters on the ground, not just in theory.

The Clinical Trial Modernization Act could help ensure that a fisherman in Hanalei has the same access to breakthrough treatments as someone in a major mainland medical center. Distance shouldn't determine who gets to fight back against cancer with every available weapon.

Federal investment in cancer research has proven itself over three decades. The advocates asked Congress to keep that momentum going, to fuel the next generation of discoveries that will drive mortality rates even lower.